Search details
1.
Galectins and Immune Responses-Just How Do They Do Those Things They Do?
Annu Rev Immunol
; 34: 243-64, 2016 05 20.
Article
in English
| MEDLINE | ID: mdl-26907217
2.
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD.
Ann Hematol
; 102(12): 3299-3309, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37817009
3.
Utility of SPR technology in biotherapeutic development: Qualification for intended use.
Anal Biochem
; 654: 114804, 2022 10 01.
Article
in English
| MEDLINE | ID: mdl-35839915
4.
A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes.
Cardiovasc Diabetol
; 16(1): 13, 2017 01 21.
Article
in English
| MEDLINE | ID: mdl-28109295
5.
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial.
Diabetes Obes Metab
; 19(11): 1610-1619, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28636754
6.
Galectin-1 regulates tissue exit of specific dendritic cell populations.
J Biol Chem
; 290(37): 22662-77, 2015 Sep 11.
Article
in English
| MEDLINE | ID: mdl-26216879
7.
The road less traveled: regulation of leukocyte migration across vascular and lymphatic endothelium by galectins.
J Clin Immunol
; 31(1): 2-9, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-20859666
8.
A new function for LAT and CD8 during CD8-mediated apoptosis that is independent of TCR signal transduction.
Eur J Immunol
; 39(6): 1619-31, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-19449311
9.
Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials.
J Diabetes Complications
; 30(7): 1378-84, 2016.
Article
in English
| MEDLINE | ID: mdl-27396241
10.
Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia.
Postgrad Med
; 128(8): 747-754, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27684308
11.
Assessing the roles of galectins in regulating dendritic cell migration through extracellular matrix and across lymphatic endothelial cells.
Methods Mol Biol
; 1207: 215-29, 2015.
Article
in English
| MEDLINE | ID: mdl-25253143
12.
[Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA® trial]. / Kardiovaskuläre Studien-Endpunkte bei Typ-2-Diabetes und die Sulfonylharnstoff-Kontroverse: Rationale für die aktiv kontrollierte CAROLINA®-Studie.
Dtsch Med Wochenschr
; 140(11): 831-4, 2015 May.
Article
in German
| MEDLINE | ID: mdl-26080724
13.
Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial.
Adv Ther
; 32(3): 201-15, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25805187
14.
Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a ≥52-week randomized, double-blind study.
Diabetes Care
; 36(12): 3875-81, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24062327
15.
Letter to the editor regarding: "Pharmacokinetics of teneligliptin in subjects with renal impairment." Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.
Clin Pharmacol Drug Dev
; 3(5): 417-8, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-27129015
Results
1 -
15
de 15
1
Next >
>>